Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.
Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.
Hepatitis A and B can be prevented with vaccines, and hepatitis C can be cured with antiviral treatment.
However, people with cirrhosis alone were as likely to die as those with both cirrhosis and COVID-19.
Liver scarring was associated with poorer health outcomes and a higher risk of death for people with non-alcoholic fatty liver disease.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Those with fatty liver disease and cirrhosis should undergo regular screening.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
People with liver cirrhosis often have substantial financial burden that interferes with their care.
The link between diabetes and liver disease
Researchers have presented findings from the first large cohort of people followed over a lengthy period to assess this connection.
Beware the damage that too much eating and drinking can do to your body.
A new study examines the clinical and economic impact of new direct-acting antivirals.
How does drinking affect people living with hepatitis C?
A new roundtable report summarizes key findings from recent studies outlining coffee’s likely contributions to protecting the liver.
Men and people over age 50 still may still develop liver cancer after clearing the virus from the blood.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.